Appropriate use of tocilizumab in COVID-19 infection

Appropriate use of tocilizumab in COVID-19 infection

Objective: This study aimed to describe the effectiveness and optimum use of tocilizumab (TCZ) treatment by the support of clinical, laboratory and radiologic observations. Methods: All patients were followed up in the hospital with daily interleukin-6 (IL-6), C-reactive protein (CRP), ferritin, d-d...

Full description

Bibliographic Details
Main Authors:	Şiran Keske, Süda Tekin, Bilgin Sait, Pelin İrkören, Mahir Kapmaz, Cansu Çimen, Semra Uğur, İrfan Çelebi, Veli Oğuzalp Bakır, Erhan Palaoğlu, Evren Şentürk, Benan Çağlayan, Nahit Çakar, Levent Tabak, Önder Ergönül
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	International Journal of Infectious Diseases
Subjects:	Tocilizumab COVID-19 Cytokines Interleukin-6 Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220305804

Similar Items

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Comparison of Tocilizumab and Anakinra in the Treatment of COVID-19: A Single-Center Experience
by: Bengisu Pınar Acat, et al.
Published: (2022-08-01)

Subcutaneous Tocilizumab May Be Effective in Refractory Fibromyalgia Patients
by: Kuo-Tung Tang, et al.
Published: (2023-06-01)

Desensibilización exitosa con tocilizumab. Reporte de un caso
by: Luis Fernando Ramírez-Zuluaga, et al.
Published: (2018-06-01)

Α Case of Severe Thyroid Eye Disease Treated with Tocilizumab
by: Aysel Mehmet, et al.
Published: (2021-04-01)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
by: Han Joo Baek, et al.
Published: (2019-07-01)

Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica
by: Federica Filippi, et al.
Published: (2019-12-01)

PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2016-02-01)

Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy
by: David van Duin, et al.
Published: (2011-04-01)

Efficacy of Low-Dose Tocilizumab on a Relapse of Adult-Onset Still’s Disease
by: Xavier Vandemergel, et al.
Published: (2016-04-01)

Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics
by: Alyaa Elhazmi, et al.
Published: (2023-03-01)

Efficacy of Tocilizumab in Patients with COVID-19
by: Ahmad Alikhani, et al.
Published: (2022-12-01)

A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report
by: Margaux Boistault, et al.
Published: (2021-12-01)

Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection
by: Al Shaimaa Ibrahim Rabie, et al.
Published: (2023-02-01)

Effect of tocilizumab on acinetobacter baumannii lung infection in an immunosuppressed rat model
by: Demet CELEBI, et al.
Published: (2021-12-01)

Tocilizumab therapy for COVID-19: A comparison of subcutaneous and intravenous therapies
by: Monica A. Kaminski, et al.
Published: (2020-12-01)

Tocilizumab: A potent immunomodulatory agent in the treatment of COVID-19 pneumonia
by: Sameer Bansal, et al.
Published: (2021-01-01)

Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil
by: Sungeun Hwang, et al.
Published: (2021-01-01)

Preliminary Efficacy of Tocilizumab Treatment in the Patients with COVID-19
by: Yu Chen, et al.
Published: (2021-04-01)

Predictors of Mortality in Tocilizumab-Treated Severe COVID-19
by: Konstantinos Pagkratis, et al.
Published: (2022-06-01)

THE CLINICAL AND PARACLINICAL EFFICACY OF TOCILIZUMAB IN JUVENILE IDIOPATHIC ARTHRITIS
by: Ninel REVENCO, et al.
Published: (2021-06-01)

Bone-sparing effects of tocilizumab in rheumatoid arthritis: a monocentric observational study
by: Suhel Gabriele Al Khayyat, et al.
Published: (2022-11-01)

Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
by: Fabrice Camou, et al.
Published: (2022-09-01)

PREDICTION OF TOCILIZUMAB AND RITUXIMAB EFFECTIVENESS IN RHEUMATOID ARTHRITIS
by: Volkava M. V.
Published: (2019-11-01)

Tocilizumab and Renal Artery Stent–Therapeutic Strategy for Takayasu Arteritis
by: Srividhya Karunanithi, et al.
Published: (2022-07-01)

Efficacy of tocilizumab treatment in severely ill COVID-19 patients
by: Jie Zhao, et al.
Published: (2020-08-01)

Neumonía por COVID-19 y uso de tocilizumab
by: Ursula Cáceres-Bernaola, et al.
Published: (2020-07-01)

Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab
by: Jonathan P. Donnelly, et al.
Published: (2021-01-01)

Estudio multicéntrico no intervencional en pacientes con artritis reumatoidea tratados con tocilizumab
by: F. Montoya, et al.
Published: (2017-09-01)

Estudio multicéntrico no intervencional en pacientes con artritis reumatoidea tratados con tocilizumab
by: F. Montoya
Published: (2015-09-01)

Potential role of tocilizumab in severe gastrointestinal barrier damage after CAR T-cell therapy
by: David Beauvais, et al.
Published: (2021-04-01)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
by: Rossella Talotta, et al.
Published: (2018-06-01)

TOCILIZUMAB IMPACT ON BLOOD CHOLESTERINE TRANSPORT AND EARLY MANIFESTATION OF ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: T V Popkova, et al.
Published: (2012-05-01)

Tocilizumab (Actemra)
by: Martin Sheppard, et al.
Published: (2017-09-01)

The association between Acinetobacter baumannii infections and the COVID-19 pandemic in an intensive care unit
by: Jale Boral, et al.
Published: (2022-12-01)

EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
by: M. I. Kaleda, et al.
Published: (2015-04-01)

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
by: Tom van Kraaij, et al.
Published: (2020-04-01)

Tocilizumab use in pediatric thyroid eye disease: First documented case
by: Safiya Albrashdi, et al.
Published: (2022-03-01)

Impact of tocilizumab therapy on fatigue in patients with rheumatoid arthritis
by: Anna Sergeyevna Starkova, et al.
Published: (2012-06-01)

Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
by: Umesha Boregowda, et al.
Published: (2020-10-01)